Pal D - Search Results

1

Discovery of novel inhibitors for the treatment of glaucoma.

Cholkar K, Trinh HM, Pal D, Mitra AK. Cholkar K, et al. Among authors: pal d. Expert Opin Drug Discov. 2015 Mar;10(3):293-313. doi: 10.1517/17460441.2015.1000857. Epub 2015 Jan 9. Expert Opin Drug Discov. 2015. PMID: 25575654 Free PMC article. Review.

2

Recent perspectives on the delivery of biologics to back of the eye.

Joseph M, Trinh HM, Cholkar K, Pal D, Mitra AK. Joseph M, et al. Among authors: pal d. Expert Opin Drug Deliv. 2017 May;14(5):631-645. doi: 10.1080/17425247.2016.1227783. Epub 2016 Sep 6. Expert Opin Drug Deliv. 2017. PMID: 27573097 Free PMC article. Review.

3

How are we improving the delivery to back of the eye? Advances and challenges of novel therapeutic approaches.

Agrahari V, Agrahari V, Mandal A, Pal D, Mitra AK. Agrahari V, et al. Among authors: pal d. Expert Opin Drug Deliv. 2017 Oct;14(10):1145-1162. doi: 10.1080/17425247.2017.1272569. Epub 2016 Dec 28. Expert Opin Drug Deliv. 2017. PMID: 27967247 Review.

4

Identification and functional characterization of riboflavin transporter in human-derived retinoblastoma cell line (Y-79): mechanisms of cellular uptake and translocation.

Kansara V, Pal D, Jain R, Mitra AK. Kansara V, et al. Among authors: pal d. J Ocul Pharmacol Ther. 2005 Aug;21(4):275-87. doi: 10.1089/jop.2005.21.275. J Ocul Pharmacol Ther. 2005. PMID: 16117691

5

Molecular evidence and functional expression of a novel drug efflux pump (ABCC2) in human corneal epithelium and rabbit cornea and its role in ocular drug efflux.

Karla PK, Pal D, Quinn T, Mitra AK. Karla PK, et al. Among authors: pal d. Int J Pharm. 2007 May 4;336(1):12-21. doi: 10.1016/j.ijpharm.2006.11.031. Epub 2006 Nov 15. Int J Pharm. 2007. PMID: 17156953 Free PMC article.

6

MDR- and CYP3A4-mediated drug-drug interactions.

Pal D, Mitra AK. Pal D, et al. J Neuroimmune Pharmacol. 2006 Sep;1(3):323-39. doi: 10.1007/s11481-006-9034-2. Epub 2006 Aug 2. J Neuroimmune Pharmacol. 2006. PMID: 18040809 Review.

7

Stereoselective evasion of P-glycoprotein, cytochrome P450 3A, and hydrolases by peptide prodrug modification of saquinavir.

Wang Z, Pal D, Mitra AK. Wang Z, et al. Among authors: pal d. J Pharm Sci. 2012 Sep;101(9):3199-213. doi: 10.1002/jps.23193. Epub 2012 May 18. J Pharm Sci. 2012. PMID: 22611042

8

Mitochondrial localization of P-glycoprotein and peptide transporters in corneal epithelial cells--novel strategies for intracellular drug targeting.

Barot M, Gokulgandhi MR, Pal D, Mitra AK. Barot M, et al. Among authors: pal d. Exp Eye Res. 2013 Jan;106:47-54. doi: 10.1016/j.exer.2012.10.006. Epub 2012 Oct 29. Exp Eye Res. 2013. PMID: 23116562 Free PMC article.

9

Novel biotinylated lipid prodrugs of acyclovir for the treatment of herpetic keratitis (HK): transporter recognition, tissue stability and antiviral activity.

Vadlapudi AD, Vadlapatla RK, Earla R, Sirimulla S, Bailey JB, Pal D, Mitra AK. Vadlapudi AD, et al. Among authors: pal d. Pharm Res. 2013 Aug;30(8):2063-76. doi: 10.1007/s11095-013-1059-7. Epub 2013 May 9. Pharm Res. 2013. PMID: 23657675 Free PMC article.

10

Mechanisms of drug resistance in cancer chemotherapy: coordinated role and regulation of efflux transporters and metabolizing enzymes.

Vadlapatla RK, Vadlapudi AD, Pal D, Mitra AK. Vadlapatla RK, et al. Among authors: pal d. Curr Pharm Des. 2013;19(40):7126-40. doi: 10.2174/13816128113199990493. Curr Pharm Des. 2013. PMID: 23829373 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,387 results

Search Page